Auto-generated event page
[CROI 2026] San Francisco AIDS Foundation: New research: High prevention efficacy and “breakthrough infections” on lenacapavir for PrEP - European AIDS Treatment Group
[CROI 2026] San Francisco AIDS Foundation: New research: High prevention efficacy and “breakthrough infections” on lenacapavir for PrEP European AIDS Treatment Group
Score 41
low confidence
1 source posts
Updated Mar 1, 2026, 11:10 PM UTC